Patents
Patents for C07C 311 - Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups (17,647)
02/2006
02/14/2006CA2363145C Oxamic acids and derivatives as thyroid receptor ligands
02/14/2006CA2296237C Essentially colorless, transparent polyimide coatings and films
02/14/2006CA2192645C Tri-substituted phenyl derivatives useful as pde iv inhibitors
02/09/2006WO2006014405A2 Sulfonamide-based compounds as protein tyrosine kinase inhibitors
02/09/2006US20060030618 Vanilloid receptor ligands and their use in treatments
02/09/2006US20060030599 Sulphonamide derivatives
02/09/2006US20060030553 Cell adhesion inhibitors
02/08/2006EP1318978B1 N-acylsulfonamide apoptosis promoters
02/08/2006EP0932600B1 Sulfonamide substituted aspartic acid interleukin-1beta converting enzyme inhibitors
02/08/2006CN1732161A 1,3-diamino-2-hydroxypropane pro-drug derivatives
02/08/2006CN1732151A 4-nitro-2-[(4'-methoxyl)-phenoxy]-toluenesulfonamide derivant and its medical uses
02/08/2006CN1732146A Cycloalkyl inhibitors of potassium channel function
02/08/2006CN1732145A Chiral arylketones in the treatment of neutrophil-dependent inflammatory diseases
02/08/2006CN1240677C Monofluoroalkyl derivatives
02/07/2006US6995285 ABCA-1 elevating compounds
02/07/2006US6995283 Benzophenones as inhibitors of reverse transcriptase
02/07/2006CA2268484C Cyclobutyl-aryloxyarylsulfonylamino hydroxamic acid derivatives
02/02/2006WO2006011035A1 Novel dipeptidyl peptidase iv inhibitors; process for their preparation and compositions containing them
02/02/2006US20060025594 Small molecule entry inhibitors
02/02/2006US20060025415 Compositions useful as inhibitors of voltage-gated sodium channels
02/01/2006EP1620422A2 Phenyl substituted carboxylic acids as inhibitors of protein tyrosine phosphatase-1b
02/01/2006EP1463707A4 A group of novel anti-cancer compounds with specific structure
02/01/2006EP0901996B1 Process for producing optically active amines
02/01/2006CN1729171A Modulation of anxiety through blockade of anandamide hydrolysis
02/01/2006CN1239472C HIV integrase inhibitors
01/2006
01/31/2006CA2327498C Process for alkylating hindered sulfonamides useful in the production of matrix metalloproteinase inhibitors
01/26/2006WO2005118528A3 Aryl alkyl sulfonamides as therapeutic agents for the treatment of bone conditions
01/26/2006WO2005097788A3 Sulfonamides and uses thereof
01/26/2006WO2005075973A3 Acousto-mechanical detection systems and methods of use
01/26/2006US20060020039 E.g., 3-(2-(4-[(2-aminosulfonyl)phenyl]benzoylamino)phenoxy)benzamidine; 7-(2-(4-[(2-aminosulfonyl)phenyl]benzoylamino)-4-fluorophenoxy)1-aminoisoquinoline; and 3-(2-(4-[(2-aminosulfonyl)phenyl]phenylaminocarbonyl-4-chlorophenoxy)benzamidine; highly selective
01/26/2006CA2574217A1 Diamine derivative, process of preparation thereof, and fungicide comprising diamine derivative as an active ingredient
01/25/2006EP1619189A1 N-(3-acyl-2-hydroxyalkyl) cycloalkyl amide derivatives
01/25/2006EP1618087A2 Antibacterial agents
01/24/2006US6989402 Thyroid receptor ligands and method II
01/24/2006US6989399 Antiamyloid phenylsulfonamides: N-alkanol derivatives
01/24/2006CA2166415C Acylated aminophenylsulfonylureas; preparation and use as herbicides and plant growth regulators
01/19/2006WO2006005909A1 Substituted acids for the treatment of respiratory diseases
01/19/2006US20060014783 Sulfonylamino-acetic acid derivatives
01/19/2006US20060014743 Methods of preventing bacterial infections with florfenicol-type antibiotics
01/19/2006US20060014701 Novel amide derivatives as growth hormone secretagogues
01/19/2006US20060014644 Phenylsulfonyl ureas, process for their preparation and their use as herbicides and plant growth regulators
01/18/2006EP1616867A1 Hydroxycarboxylic acid derivatives
01/18/2006EP1616865A1 Inhibition of p38 kinase using symmetrical and unsymmetrical diphenyl ureas
01/18/2006EP1616859A1 Substituted cyclohexyl carboxylic acid compounds
01/18/2006EP1615899A1 Alpha-substituted carboxylic acids as ppar modulators
01/18/2006EP1615866A1 Indene derivatives as pharmaceutical agents
01/18/2006EP1615629A1 Peptide deformylase inhibitors
01/18/2006EP1226819B1 Inhibitor for 20-hete-yielding enzyme
01/18/2006CN1723207A Inhibitors of histone deacetylase
01/18/2006CN1723194A 3,4-di-substituted cyclobutene-1,2-diones as CXC-chemokine receptor ligands
01/18/2006CN1723059A Insulin receptor activators for the treatment of human body metabolic disorder resulting from treatment of HIV infection with HIV protease inhibitors
01/18/2006CN1721407A New asymmetric process for the preparation of diarylmethylpiperazines derivatives and novel asymmetric diarylmetylamines as intermediates
01/18/2006CN1721401A Inhibitors of LFA-1 binding to ICAMS and uses thereof
01/18/2006CN1721397A Omega-carboxyaryl substituted diphenyl ureas as raf kinase inhibitors
01/18/2006CN1721052A Waterpower liquid
01/18/2006CN1236845C Bis (perfluoroalkanesulfonyl)imides and their salts as surfactants/additives for applications having extreme environments and methods thereof
01/17/2006US6987198 Acid generator and thin film composition containing the same
01/17/2006US6987174 an azo compound with a sulfonate, sulfonamide and aminonaphthyl groups; light fastness, heat resistance, insolubility in water, organic solvent
01/17/2006CA2138930C Substituted benzenesulfonylureas and -thioureas, preparation processes and possible uses of pharmaceutical preparations based on these compounds
01/12/2006WO2006003923A1 Substituted benzene compound
01/12/2006WO2006003495A1 Substituted heteroaryl- and phenylsulfamoyl compounds
01/12/2006WO2005094810A3 Novel pharmaceutical compositions
01/12/2006US20060009651 Benzophenones as inhibitors of reverse transcriptase
01/12/2006US20060009511 N-(2-arylethyl) benzylamines as antagonists of the 5-ht6 receptor
01/12/2006DE102004030987A1 Ortho-substituierte (3-Hydroxyphenyl)-essigsäure-benzyliden-hydrazide Ortho-substituted (3-hydroxyphenyl) -acetic acid benzylidene-hydrazide
01/12/2006CA2573193A1 Substituted heteroaryl- and phenylsulfamoyl compounds
01/11/2006EP1614678A2 Sulfur substituted sulfonylaminocarboxylic acid N-heteroarylamides, their preparation, their use and pharmaceutical preparations comprising them
01/11/2006EP1613268A2 Methods for inhibition of angiogenesis
01/11/2006EP1127036B1 Sulphonylation method and reagent useful for perhalogenated sulphanilide synthesis
01/11/2006EP1107951B1 Homo- or copolymeric material based on sulfonylimides possessing a polymerizable group
01/10/2006US6984757 reacting 2-[-1-amino-1-(4-flourophenyl)methylene]-4-alkyl-3-oxo-alkanoic acid ester with N-cyano-N-alkylalkanesulfonamide; HMG-Co A reductase inhibitors
01/10/2006US6984756 Combining a phenyl boronic acid derivative with a suitable benzene derivative in the presence of a suitable additive in a suitable organic solvent with a suitable catalyst and a suitable base to form biphenyl compound
01/10/2006US6984645 Aryl carboxylic acids and tetrazoles for treating diabetes, especially type II diabetes
01/05/2006WO2006000293A1 Ortho-substituted (3-hydroxyphenyl)-acetic acid benzylidene hydrazides
01/05/2006WO2006000288A1 Phenylcarboxylic acid derivatives and use thereof for the treatment of diabetes
01/05/2006WO2005065398A3 Synthesis of ionic liquids
01/05/2006US20060004197 Sulfonamide-based compounds as protein tyrosine kinase inhibitors
01/05/2006US20060004106 For urogenital disorders; improved side effect reduction, bioavailability, pharmacokinetics and half-life; N,N-diisopropyl-3-(2-methoxy-5-trifluoromethylphenyl)-3-phenylpropanamine
01/05/2006US20060004066 Method for treating ADAMTS-5-associated disease
01/05/2006CA2572153A1 Phenylcarboxylic acid derivatives and use thereof for the treatment of diabetes
01/05/2006CA2572135A1 Sulfonamide compound
01/05/2006CA2571990A1 Ortho-substituted (3-hydroxyphenyl)-acetic acid benzylidene hydrazides
01/05/2006CA2571309A1 Chemical compounds
01/04/2006EP1611091A1 Novel compounds
01/04/2006EP1610753A2 Phenylenediamine urotensin-ii receptor antagonists and ccr-9 antagonists
01/04/2006EP1383741A4 Process for the preparation of benazepril
01/03/2006US6982348 for example, N[(1RS2SR)-2-(4-fluorophenyl)-2-hydroxy-1-[4-fluoromethyl)benzyl]ethyl]-6,7-dihydro-5H-benzo[a]cycloheptene-1-carboxamide; cholesteryl ester transfer protein inhibitory action; lipid-lowering agents
01/03/2006US6982344 Process for preparation of optically active sulfonamides and intermediates for their synthesis
12/2005
12/29/2005WO2005123646A2 Fluoroorganic compounds and anti-fouling treatments
12/29/2005WO2005085189A3 Analogues of congo red and evaluation of their anti-prion activity
12/29/2005WO2005077122A3 Compounds and compositions as lxr modulators
12/29/2005US20050288369 Novel n-hydroxy thiourea, urea and amide compounds and the pharmaceutical compositions comprising the same
12/29/2005US20050288340 Substituted heteroaryl- and phenylsulfamoyl compounds
12/29/2005US20050288282 Anticancer agents; antiproliferative agents
12/29/2005US20050287109 N-halo-4-carboxybenzene sulfonamides; soap, lotion, wipe, or swab; minimal side effects; bactericide, pesticide, fungicide, deodorizing; also bovine teat cleaners, drugs for cultured fish, soap biocides, stain removal agents, and paint fungicides; paper mill sludge and sewerage treatment sludge
12/29/2005DE19748040B4 Carbonsäurederivate, Verfahren zu ihrer Herstellung und pharmazeutische Präparate, die diese Verbindungen enthalten Carboxylic acid derivatives, processes for their preparation and pharmaceutical preparations containing these compounds
12/29/2005DE102004027912A1 Substituierte Cyclopenten-Verbindungen Substituted cyclopentene compounds
12/28/2005EP1608616A1 Biphenyl carboxylic amide p38 kinase inhibitors
12/28/2005EP1608374A1 2-phenoxy- and 2-phenylsulfomamide derivatives with ccr3 antagonistic activity for the treatment of asthma and other inflammatory or immunological disorders
12/28/2005EP1608319A2 Improved inhibitors for the soluble epoxide hydrolase
1 ... 47 48 49 50 51 52 53 54 55 56 57 58 59 60 61 62 63 64 65 66 67 ... 177